{"disease":{"id":"mismatch-repair-protein-proficient","name":"mismatch repair protein proficient"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03396926","title":"Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"University of California, San Francisco","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}